Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
H746885-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $56.90 | |
H746885-500μl | 500μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $181.90 | |
H746885-3ml | 3ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $549.90 |
Specifications & Purity | 100X |
---|---|
Stability And Storage | Store at -20℃ in the dark for up to 1 year. |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Precautions: The concentration of this product has been optimized by to meet the needs of nuclear staining in live cells and other routine nuclear staining . If other concentrations of Hoechst 33342 are required, please purchase ’s Hoechst 33342 in powder form . Fluorescent dyes quench. Stained samples should be examined on the same day after staining.To slow down the quenching of fluorescence, we recommend mounting slides with ’s Antifade Mounting Medium .Hoechst 33342 is harmful. Please take effective measures to avoid inhalation or direct contact with skin or eyes.This product is for R&D only. Not for drug, household, or other uses.For your safety and health, please wear a lab coat and disposable gloves during the operation.Instructions for Use: 1.Staining of live cells or tissuesa.For live cells or tissues in culture dishes, add the Hoechst 33342 Staining Solution for Live Cells (100X) to cell culture to a final concentration of 1X, and mix well gently. For example, for cells cultured in 12-well plates with 1 ml of culture per well, add 10 μl of Hoechst 33342 Staining Solution for Live Cells (100X) per well. Neither the serum nor the phenol red in culture will interfere with the staining.b.Incubate at a temperature suitable for cell growth for 10 minutes. Aspirate the culture medium containing the dye and wash 2-3 times with culture medium or PBS before observation under a fluorescence microscope. The nuclei of apoptotic cells can be densely stained, or fragmented and densely stained. If the requirement of staining effect is not particularly high, the cells can be observed after 5 minutes of staining and one washing with culture medium or PBS. To avoid removal of apoptotic cells when aspirating culture medium and washing after staining, centrifuge the cells in multi-well plates before aspiration in order to sediment the floating apoptotic cells.2.Staining of fixed cells or tissuesa.Cell or tissue samples can be stained directly with this product after fixation and washing appropriately. However, if immunofluorescence staining of the sample is required, perform immunofluorescence staining first, and then Hoechst 33342 staining. b.For adherent cells or tissue sections, add a small amount of Hoechst 33342 Staining Solution to cover the sample. For suspension cells, add the Hoechst 33342 Staining Solution at least 3 times the volume of the sample, and mix well.c.Leave the sample at room temperature for 3-5 minutes. d.Aspirate the Hoechst 33342 Staining Solution and wash with TBST, PBS or saline for 2-3 times, each time for 3-5 minutes.e.Observe under the fluorescence microscope directly or after mounting. The nuclei of apoptotic cells can be densely stained or fragmented and densely stained.Related Products:Cat. No.Product NamePack SizeC1002DAPI5mg/ml×0.2mlC1005DAPI Staining Solution 10mlC1006DAPI Staining Solution50mlC1011Hoechst 3325810mgC1017Hoechst 33258 Staining Solution10mlC1018Hoechst 33258 Staining Solution50mlC1022Hoechst 3334210mgC1025Hoechst 33342 Staining Solution10mlC1026Hoechst 33342 Staining Solution for Live Cells (100X)50mlC1027Hoechst 33342 Staining Solution for Live Cells (100X)0.1mlC1028Hoechst 33342 Staining Solution for Live Cells (100X) 0.5mlC1029Hoechst 33342 Staining Solution for Live Cells (100X)3ml |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | 2-(4-ethoxyphenyl)-6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazole |
---|---|
INCHI | InChI=1S/C27H28N6O/c1-3-34-21-8-4-18(5-9-21)26-28-22-10-6-19(16-24(22)30-26)27-29-23-11-7-20(17-25(23)31-27)33-14-12-32(2)13-15-33/h4-11,16-17H,3,12-15H2,1-2H3,(H,28,30)(H,29,31) |
InChi Key | PRDFBSVERLRRMY-UHFFFAOYSA-N |
Canonical SMILES | CCOC1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)C4=NC5=C(N4)C=C(C=C5)N6CCN(CC6)C |
Isomeric SMILES | CCOC1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)C4=NC5=C(N4)C=C(C=C5)N6CCN(CC6)C |
WGK Germany | 3 |
Alternate CAS | 875756-97-1 |
PubChem CID | 1464 |
Molecular Weight | 561.93(anhydrous basis) |
Beilstein | 1234011 |
Enter Lot Number to search for COA:
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H335:May cause respiratory irritation H341:Suspected of causing genetic defects H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P281:Use personal protective equipment as required. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
1. Cheng Shen, Yachao Li, Zenan Zeng, Yiming Liu, Yini Xu, Kefurong Deng, Beiling Guo, Dongzhe Zou, Liguo Liu, Xiaoyu Liang, Xianghui Xu. (2023) Systemic Administration with Bacteria-Inspired Nanosystems for Targeted Oncolytic Therapy and Antitumor Immunomodulation. ACS Nano, 17 (24): (25638–25655). [PMID:38064380] |
2. Zihan He, Haoying Song, Jingjing Cheng, Wenxiu Qiu, Junjie Hu, Zhenpeng Qiu, Qi Wang, Cong Chang, Guohua Zheng, Yan Meng. (2023) Selenium Nanoparticles Stabilized by β-Glucan Nanotubes from Black Fungus and Their Effects on the Proliferation, Apoptosis, and Cell Cycle of HepG2 Cells. ACS Omega, [PMID:38075754] |
3. Yao Yuying, Wang Yeru, Zhu Jingru, Guo Zhiqiang, Li Zongqiang, Li Qianru, Liu Su, Wang Yu, Yu Jinghua, Huang Jiadong. (2023) A spatially-controlled DNA triangular prism nanomachine for AND-gated intracellular imaging of ATP in acidic microenvironment. MICROCHIMICA ACTA, 190 (11): (1-9). [PMID:37837554] |
4. Lianxue Zhang, Jianxiang Huang, Damiano Buratto, Panli Han, Zaixing Yang, Ruhong Zhou. (2023) A pH-responsive nanoparticle delivery system containing dihydralazine and doxorubicin-based prodrug for enhancing antitumor efficacy. Aggregate, 5 (1): (e434). [PMID:16580887] |
5. Gang Liu, Mingyu Liu, Xiujing Li, Xiaorong Ye, Kaiming Cao, Yangzhong Liu, Yue Yu. (2023) Peroxide-Simulating and GSH-Depleting Nanozyme for Enhanced Chemodynamic/Photodynamic Therapy via Induction of Multisource ROS. ACS Applied Materials & Interfaces, 15 (41): (47955–47968). [PMID:37812458] |
6. Liang Liang, Jin Ren, Jun Dai, Jianyun Liu, Lifang Zhang, Donglin Li, Chao Yang, Jingmou Yu. (2023) Layered double hydroxides - poloxamer 188 nanocomposites based on exfoliation reassembling for improved cellular uptake and controlled delivery of methotrexate. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, [PMID:37577952] |
7. Jingmou Yu, Liangliang Wang, Yun Ling, Xin Xiao, Juntao Gong, Hongguang Jin, Jing Xu, Pu Chen, Xin Xie, Lei Zhang. (2023) Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer. COLLOIDS AND SURFACES B-BIOINTERFACES, 227 (113381). [PMID:37257299] |
8. Zheng Hua, Xuedi Zhang, Yannan Chen, Ronggang Liu, Yu Li, Jiaxuan Li, Donghong Liu, Mingqian Tan. (2023) A bifunctional hepatocyte-mitochondrion targeting nanosystem for effective astaxanthin delivery to the liver. FOOD CHEMISTRY, 424 (136439). [PMID:37245472] |
9. Rui Chang, Rongrong Fu, Yujiao Huang, Jibing Zhang, Changshun Feng, Rui Wang, Hui Yan, Guangyong Li, Xiaohong Chu, Fengjiao Yuan, Dianlong Jia, Jun Li. (2023) Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors. MOLECULAR PHARMACEUTICS, [PMID:37134184] |
10. Yong Wang, Jia-Ying Ji, Kai Guo, Tao Zhang, Xin-Cao Zhong, Ze-Ming Zhuang, Yu-Fan Zhong, Xiao-Ying Lin, Yong-Zhong Du, Jian Chen, Wei Qiang Tan. (2023) Gene liposome nanocomplex-loaded dermal substitute promotes diabetic chronic wound healing and angiogenesis in rat. BIOMEDICINE & PHARMACOTHERAPY, 163 (114794). [PMID:37121150] |
11. Zhang Yufei, Cheng Qian, Xue Yuhao, Yao Kai, Syeda Madiha Zahra, Xu Jian, Wu Jianheng, Wang Zhenjie, Tang Longguang, Mu Qingchun. (2023) LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy. Nano Research, (1-9). [PMID:] |
12. Yanan Li, Weikang Liang, Chenghua Li. (2023) Exogenous adenosine and/or guanosine enhances tetracycline sensitivity of persister cells. MICROBIOLOGICAL RESEARCH, 270 (127321). [PMID:36773473] |
13. Delong Hou, Yong Xu, Jun Yan, Qi Zeng, Zhonghui Wang, Yi Chen. (2023) Intracellularly Self-Assembled 2D Materials Induce Apoptotic Cell Death by Impeding Cytosolic Transport. ACS Nano, 17 (3): (3055–3063). [PMID:36688625] |
14. Jingmou Yu, Liangliang Wang, Xin Xie, Wenjing Zhu, Zhineng Lei, Linghui Lv, Hongling Yu, Jing Xu, Jin Ren. (2023) Multifunctional Nanoparticles Codelivering Doxorubicin and Amorphous Calcium Carbonate Preloaded with Indocyanine Green for Enhanced Chemo-Photothermal Cancer Therapy. International Journal of Nanomedicine, [PMID:36700147] |
15. Lu Lu, Hongyuan Chen, Longkun Wang, Lin Zhao, Yanna Cheng, Aijun Wang, Fengshan Wang, Xinke Zhang. (2023) A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma. International Journal of Nanomedicine, [PMID:33209022] |
16. Hongyan Cui, Ming Zhang, Liuwei Zhang, Haidong Li, Yue Wang, Yan Zhao, Qixian Chen, Jingyun Wang. (2023) pH-responsive organic/inorganic hybrid nanocolloids for transcellular delivery of ribonucleolytic payloads toward targeted anti-glioma therapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 634 (388). [PMID:36542969] |
17. Ren Jin, Liang Liang, Yang Yongqing, Liu Xiang, Li Weidong, Liu Wenbo, Wang Yali, Yu Jingmou. (2023) Assembling drug-loaded-layered double hydroxide nanohybrids with poloxamer 188 for improved cellular uptake and in vitro efficacy. JOURNAL OF MATERIALS RESEARCH, 38 (2): (337-349). [PMID:] |
18. Zheng Hua, Xuedi Zhang, Xue Zhao, Bei-Wei Zhu, Donghong Liu, Mingqian Tan. (2023) Hepatic-targeted delivery of astaxanthin for enhanced scavenging free radical scavenge and preventing mitochondrial depolarization. FOOD CHEMISTRY, 406 (135036). [PMID:36459794] |
19. Hongyan Cui, Liuwei Zhang, Shuang Zeng, Yu Wang, Zhen Li, Jingyun Wang, Qixian Chen. (2022) Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma. ACS Applied Materials & Interfaces, 14 (27): (30493–30506). [PMID:35657733] |
20. Huijuan Zhang, Qingqing He, Jingjing Wang, Yaping Wang, Xiangyang Xuan, Mingli Sui, Zhenzhong Zhang, Lin Hou. (2022) Biomimetic micelles to accurately regulate the inflammatory microenvironment for glomerulonephritis treatment. PHARMACOLOGICAL RESEARCH, 181 (106263). [PMID:35597383] |
21. Jianhua He, Xiaoju Zhou, Fengfei Xu, Hongliang He, Shuangyan Ma, Xinyue Liu, Mengyuan Zhang, Wenli Zhang, Jianping Liu. (2022) Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 174 (144). [PMID:35447349] |
22. Jianhua He, Wenli Zhang, Xiaoju Zhou, Fengfei Xu, Jiahui Zou, Qiqi Zhang, Yi Zhao, Hongliang He, Hu Yang, Jianping Liu. (2023) Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery. Bioactive Materials, 19 (115). [PMID:35475030] |
23. Xiangrong Tian, Li Ruan, Shengwang Zhou, Lin Wu, Jin Cao, Xueyong Qi, Xin Zhang, Song Shen. (2022) Appropriate Size of Fe3O4 Nanoparticles for Cancer Therapy by Ferroptosis. ACS Applied Bio Materials, 5 (4): (1692–1699). [PMID:35297253] |
24. Xinming Zhang, Ruijuan Lv, Lixia Chen, Ruimeng Sun, Yang Zhang, Rongtian Sheng, Ting Du, Yuhan Li, Yanfei Qi. (2022) A Multifunctional Janus Electrospun Nanofiber Dressing with Biofluid Draining, Monitoring, and Antibacterial Properties for Wound Healing. ACS Applied Materials & Interfaces, 14 (11): (12984–13000). [PMID:35266385] |
25. Qing Hu, Jiayi Yao, Xiaoqin Wang, Yanfang Wang, Xiaoling Fu, Ju Ma, Han Lin, Jiaqi Xu, Longhua Shen, Xiangbin Yu. (2022) Combinational Chemoimmunotherapy for Breast Cancer by Codelivery of Doxorubicin and PD-L1 siRNA Using a PAMAM-Incorporated Liposomal Nanoplatform. ACS Applied Materials & Interfaces, 14 (7): (8782–8792). [PMID:35138103] |
26. Yang Zhang, Lixia Chen, Ruimeng Sun, Ruijuan Lv, Ting Du, Yuhan Li, Xinming Zhang, Rongtian Sheng, Yanfei Qi. (2022) Multienzymatic Antioxidant Activity of Manganese-Based Nanoparticles for Protection against Oxidative Cell Damage. ACS Biomaterials Science & Engineering, 8 (2): (638–648). [PMID:35076222] |
27. Duo Liang, Wentao Su, Xue Zhao, Jiaxuan Li, Zheng Hua, Song Miao, Mingqian Tan. (2022) Microfluidic Fabrication of pH-Responsive Nanoparticles for Encapsulation and Colon-Target Release of Fucoxanthin. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 70 (1): (124–135). [PMID:34963047] |
28. Lixia Chen, Yang Zhang, Xinming Zhang, Ruijuan Lv, Rongtian Sheng, Ruimeng Sun, Ting Du, Yuhan Li, Yanfei Qi. (2022) A GdW10@PDA-CAT Sensitizer with High-Z Effect and Self-Supplied Oxygen for Hypoxic-Tumor Radiotherapy. MOLECULES, 27 (1): (128). [PMID:35011360] |
29. Cui Zixin, Zhang Miaomiao, Geng Songmei, Niu Xinwu, Wang Xiaopeng, Zhu Yanyan, Ye Feng, Liu Chengcheng. (2021) Antifungal Effect of Antimicrobial Photodynamic Therapy Mediated by Haematoporphyrin Monomethyl Ether and Aloe Emodin on Malassezia furfur. Frontiers in Microbiology, 12 [PMID:34867868] |
30. Qin Wang, Kai-Ni Wei, Shu-Zhen Huang, Qing Tang, Zhu Tao, Ying Huang. (2021) “Turn-Off” Supramolecular Fluorescence Array Sensor for Heavy Metal Ion Identification. ACS Omega, 6 (46): (31229–31235). [PMID:34841166] |
31. Guijie Wei, Jianhua Chen, Ziqi Jing, Yanyi Li, Zhihui Li, Wei Zheng, Xiurui Sun, Wenwen Zhao, Zhe Zhang, Xue Wang, Hongcui Han, Chu Li, Yujie Zhang, Pengkai Ma. (2022) Glucose transporter 1 (GLUT1)-targeting and hypoxia-activated mitochondria-specific chemo-thermal therapy via a glycosylated poly(amido amine)/celastrol (PAMAM/Cel) complex. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 608 (1355). [PMID:34742058] |
1. Cheng Shen, Yachao Li, Zenan Zeng, Yiming Liu, Yini Xu, Kefurong Deng, Beiling Guo, Dongzhe Zou, Liguo Liu, Xiaoyu Liang, Xianghui Xu. (2023) Systemic Administration with Bacteria-Inspired Nanosystems for Targeted Oncolytic Therapy and Antitumor Immunomodulation. ACS Nano, 17 (24): (25638–25655). [PMID:38064380] |
2. Zihan He, Haoying Song, Jingjing Cheng, Wenxiu Qiu, Junjie Hu, Zhenpeng Qiu, Qi Wang, Cong Chang, Guohua Zheng, Yan Meng. (2023) Selenium Nanoparticles Stabilized by β-Glucan Nanotubes from Black Fungus and Their Effects on the Proliferation, Apoptosis, and Cell Cycle of HepG2 Cells. ACS Omega, [PMID:38075754] |
3. Yao Yuying, Wang Yeru, Zhu Jingru, Guo Zhiqiang, Li Zongqiang, Li Qianru, Liu Su, Wang Yu, Yu Jinghua, Huang Jiadong. (2023) A spatially-controlled DNA triangular prism nanomachine for AND-gated intracellular imaging of ATP in acidic microenvironment. MICROCHIMICA ACTA, 190 (11): (1-9). [PMID:37837554] |
4. Lianxue Zhang, Jianxiang Huang, Damiano Buratto, Panli Han, Zaixing Yang, Ruhong Zhou. (2023) A pH-responsive nanoparticle delivery system containing dihydralazine and doxorubicin-based prodrug for enhancing antitumor efficacy. Aggregate, 5 (1): (e434). [PMID:16580887] |
5. Gang Liu, Mingyu Liu, Xiujing Li, Xiaorong Ye, Kaiming Cao, Yangzhong Liu, Yue Yu. (2023) Peroxide-Simulating and GSH-Depleting Nanozyme for Enhanced Chemodynamic/Photodynamic Therapy via Induction of Multisource ROS. ACS Applied Materials & Interfaces, 15 (41): (47955–47968). [PMID:37812458] |
6. Liang Liang, Jin Ren, Jun Dai, Jianyun Liu, Lifang Zhang, Donglin Li, Chao Yang, Jingmou Yu. (2023) Layered double hydroxides - poloxamer 188 nanocomposites based on exfoliation reassembling for improved cellular uptake and controlled delivery of methotrexate. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, [PMID:37577952] |
7. Jingmou Yu, Liangliang Wang, Yun Ling, Xin Xiao, Juntao Gong, Hongguang Jin, Jing Xu, Pu Chen, Xin Xie, Lei Zhang. (2023) Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer. COLLOIDS AND SURFACES B-BIOINTERFACES, 227 (113381). [PMID:37257299] |
8. Zheng Hua, Xuedi Zhang, Yannan Chen, Ronggang Liu, Yu Li, Jiaxuan Li, Donghong Liu, Mingqian Tan. (2023) A bifunctional hepatocyte-mitochondrion targeting nanosystem for effective astaxanthin delivery to the liver. FOOD CHEMISTRY, 424 (136439). [PMID:37245472] |
9. Rui Chang, Rongrong Fu, Yujiao Huang, Jibing Zhang, Changshun Feng, Rui Wang, Hui Yan, Guangyong Li, Xiaohong Chu, Fengjiao Yuan, Dianlong Jia, Jun Li. (2023) Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors. MOLECULAR PHARMACEUTICS, [PMID:37134184] |
10. Yong Wang, Jia-Ying Ji, Kai Guo, Tao Zhang, Xin-Cao Zhong, Ze-Ming Zhuang, Yu-Fan Zhong, Xiao-Ying Lin, Yong-Zhong Du, Jian Chen, Wei Qiang Tan. (2023) Gene liposome nanocomplex-loaded dermal substitute promotes diabetic chronic wound healing and angiogenesis in rat. BIOMEDICINE & PHARMACOTHERAPY, 163 (114794). [PMID:37121150] |
11. Zhang Yufei, Cheng Qian, Xue Yuhao, Yao Kai, Syeda Madiha Zahra, Xu Jian, Wu Jianheng, Wang Zhenjie, Tang Longguang, Mu Qingchun. (2023) LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy. Nano Research, (1-9). [PMID:] |
12. Yanan Li, Weikang Liang, Chenghua Li. (2023) Exogenous adenosine and/or guanosine enhances tetracycline sensitivity of persister cells. MICROBIOLOGICAL RESEARCH, 270 (127321). [PMID:36773473] |
13. Delong Hou, Yong Xu, Jun Yan, Qi Zeng, Zhonghui Wang, Yi Chen. (2023) Intracellularly Self-Assembled 2D Materials Induce Apoptotic Cell Death by Impeding Cytosolic Transport. ACS Nano, 17 (3): (3055–3063). [PMID:36688625] |
14. Jingmou Yu, Liangliang Wang, Xin Xie, Wenjing Zhu, Zhineng Lei, Linghui Lv, Hongling Yu, Jing Xu, Jin Ren. (2023) Multifunctional Nanoparticles Codelivering Doxorubicin and Amorphous Calcium Carbonate Preloaded with Indocyanine Green for Enhanced Chemo-Photothermal Cancer Therapy. International Journal of Nanomedicine, [PMID:36700147] |
15. Lu Lu, Hongyuan Chen, Longkun Wang, Lin Zhao, Yanna Cheng, Aijun Wang, Fengshan Wang, Xinke Zhang. (2023) A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma. International Journal of Nanomedicine, [PMID:33209022] |
16. Hongyan Cui, Ming Zhang, Liuwei Zhang, Haidong Li, Yue Wang, Yan Zhao, Qixian Chen, Jingyun Wang. (2023) pH-responsive organic/inorganic hybrid nanocolloids for transcellular delivery of ribonucleolytic payloads toward targeted anti-glioma therapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 634 (388). [PMID:36542969] |
17. Ren Jin, Liang Liang, Yang Yongqing, Liu Xiang, Li Weidong, Liu Wenbo, Wang Yali, Yu Jingmou. (2023) Assembling drug-loaded-layered double hydroxide nanohybrids with poloxamer 188 for improved cellular uptake and in vitro efficacy. JOURNAL OF MATERIALS RESEARCH, 38 (2): (337-349). [PMID:] |
18. Zheng Hua, Xuedi Zhang, Xue Zhao, Bei-Wei Zhu, Donghong Liu, Mingqian Tan. (2023) Hepatic-targeted delivery of astaxanthin for enhanced scavenging free radical scavenge and preventing mitochondrial depolarization. FOOD CHEMISTRY, 406 (135036). [PMID:36459794] |
19. Hongyan Cui, Liuwei Zhang, Shuang Zeng, Yu Wang, Zhen Li, Jingyun Wang, Qixian Chen. (2022) Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma. ACS Applied Materials & Interfaces, 14 (27): (30493–30506). [PMID:35657733] |
20. Huijuan Zhang, Qingqing He, Jingjing Wang, Yaping Wang, Xiangyang Xuan, Mingli Sui, Zhenzhong Zhang, Lin Hou. (2022) Biomimetic micelles to accurately regulate the inflammatory microenvironment for glomerulonephritis treatment. PHARMACOLOGICAL RESEARCH, 181 (106263). [PMID:35597383] |
21. Jianhua He, Xiaoju Zhou, Fengfei Xu, Hongliang He, Shuangyan Ma, Xinyue Liu, Mengyuan Zhang, Wenli Zhang, Jianping Liu. (2022) Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 174 (144). [PMID:35447349] |
22. Jianhua He, Wenli Zhang, Xiaoju Zhou, Fengfei Xu, Jiahui Zou, Qiqi Zhang, Yi Zhao, Hongliang He, Hu Yang, Jianping Liu. (2023) Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery. Bioactive Materials, 19 (115). [PMID:35475030] |
23. Xiangrong Tian, Li Ruan, Shengwang Zhou, Lin Wu, Jin Cao, Xueyong Qi, Xin Zhang, Song Shen. (2022) Appropriate Size of Fe3O4 Nanoparticles for Cancer Therapy by Ferroptosis. ACS Applied Bio Materials, 5 (4): (1692–1699). [PMID:35297253] |
24. Xinming Zhang, Ruijuan Lv, Lixia Chen, Ruimeng Sun, Yang Zhang, Rongtian Sheng, Ting Du, Yuhan Li, Yanfei Qi. (2022) A Multifunctional Janus Electrospun Nanofiber Dressing with Biofluid Draining, Monitoring, and Antibacterial Properties for Wound Healing. ACS Applied Materials & Interfaces, 14 (11): (12984–13000). [PMID:35266385] |
25. Qing Hu, Jiayi Yao, Xiaoqin Wang, Yanfang Wang, Xiaoling Fu, Ju Ma, Han Lin, Jiaqi Xu, Longhua Shen, Xiangbin Yu. (2022) Combinational Chemoimmunotherapy for Breast Cancer by Codelivery of Doxorubicin and PD-L1 siRNA Using a PAMAM-Incorporated Liposomal Nanoplatform. ACS Applied Materials & Interfaces, 14 (7): (8782–8792). [PMID:35138103] |
26. Yang Zhang, Lixia Chen, Ruimeng Sun, Ruijuan Lv, Ting Du, Yuhan Li, Xinming Zhang, Rongtian Sheng, Yanfei Qi. (2022) Multienzymatic Antioxidant Activity of Manganese-Based Nanoparticles for Protection against Oxidative Cell Damage. ACS Biomaterials Science & Engineering, 8 (2): (638–648). [PMID:35076222] |
27. Duo Liang, Wentao Su, Xue Zhao, Jiaxuan Li, Zheng Hua, Song Miao, Mingqian Tan. (2022) Microfluidic Fabrication of pH-Responsive Nanoparticles for Encapsulation and Colon-Target Release of Fucoxanthin. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 70 (1): (124–135). [PMID:34963047] |
28. Lixia Chen, Yang Zhang, Xinming Zhang, Ruijuan Lv, Rongtian Sheng, Ruimeng Sun, Ting Du, Yuhan Li, Yanfei Qi. (2022) A GdW10@PDA-CAT Sensitizer with High-Z Effect and Self-Supplied Oxygen for Hypoxic-Tumor Radiotherapy. MOLECULES, 27 (1): (128). [PMID:35011360] |
29. Cui Zixin, Zhang Miaomiao, Geng Songmei, Niu Xinwu, Wang Xiaopeng, Zhu Yanyan, Ye Feng, Liu Chengcheng. (2021) Antifungal Effect of Antimicrobial Photodynamic Therapy Mediated by Haematoporphyrin Monomethyl Ether and Aloe Emodin on Malassezia furfur. Frontiers in Microbiology, 12 [PMID:34867868] |
30. Qin Wang, Kai-Ni Wei, Shu-Zhen Huang, Qing Tang, Zhu Tao, Ying Huang. (2021) “Turn-Off” Supramolecular Fluorescence Array Sensor for Heavy Metal Ion Identification. ACS Omega, 6 (46): (31229–31235). [PMID:34841166] |
31. Guijie Wei, Jianhua Chen, Ziqi Jing, Yanyi Li, Zhihui Li, Wei Zheng, Xiurui Sun, Wenwen Zhao, Zhe Zhang, Xue Wang, Hongcui Han, Chu Li, Yujie Zhang, Pengkai Ma. (2022) Glucose transporter 1 (GLUT1)-targeting and hypoxia-activated mitochondria-specific chemo-thermal therapy via a glycosylated poly(amido amine)/celastrol (PAMAM/Cel) complex. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 608 (1355). [PMID:34742058] |